Prof. Yuhua Ruan

Chinese Center for Disease Control and Prevention, China

Email: [email protected]

Qualifications

1999  Ph.D., Shanghai Medical University, SOPH

1996  M.S., Suzhou Medical College

Publications (Selected)

1. Chen, Y., Xu, X. S., Li, J. J., et al. (2026). Delineating the "who-where-how" of persistent HIV epidemics: a 23-year longitudinal genetic network, phylodynamic, and spatial analysis for precise intervention in rural China. Emerging Microbes & Infections, 15(1), Article 2671470.
2. Han, S. Y., He, L., Tang, Y. H., et al. (2026). Development of a Subsequence Correlation Coefficient Feature Vector Method for High-Resolution HIV-1 Subtype Classification - China, 2004-2022. China CDC Weekly, 8(16), 488-494.
3. Li, J. L., Xu, Y., Tang, Y., et al. (2026). Evaluation of a HIV-1 drug resistance genotyping method based on high-throughput sequencing (HTS). BMC Infectious Diseases, 26(1), Article 838.
4. Qin, L. T., Xie, Y. H., Li, J. J., et al. (2026). Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China. Journal of Antimicrobial Chemotherapy, 81(3), Article dkag073.
5. Zuo, Z. B., Huang, W., Liu, L., et al. (2025). HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China. Frontiers in Microbiology, 16, Article 1617795.
6. Hu, Y. Y., Sun, S. S., Liu, Y., et al. (2025). Multiple Mechanisms of HIV-1 Resistance to PGT135 in a Chinese Subtype B' Slow Progressor. Pathogens, 14(6), Article 556.
7. Hao, J. J., Liu, X., Wang, D., et al. (2025). Transmitted Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey. Clinical Infectious Diseases, 81(3), 531-538.
8. Su, J. W., Zhang, J. J., Wang, Q. Y., et al. (2025). Multiparametric Immune Profiles and Their Potential Role in HIV-1 Disease Progression and Treatment. Pathogens, 14(4), Article 347.
9. Lu, H. X., Chen, H. H., Liang, S. J., et al. (2025). Mortality and immunological indicators of men who have sex with men living with HIV on antiretroviral therapy: a 10-year retrospective cohort study in Southern China. BMC Infectious Diseases, 25(1), Article 135.
10. Hu, H. P., Hao, J. J., Wang, D., et al. (2025). Pretreatment HIV Drug Resistance to Integrase Strand Transfer Inhibitors Among Newly Diagnosed HIV Individuals - China, 2018-2023. China CDC Weekly, 7(2).
11. Chen, Y., Xu, X. S., Chen, H. H., et al. (2025). Impact of HIV Pretreatment Drug Resistance on Secondary Transmission Through Treatment Dropout: A Prospective Population-Based Study in Southwestern China. Infection and Drug Resistance, 18, 2311-2327.
12. Sun, X. D., Zhou, W. K., Ruan, Y. H., et al. (2025). Perceived risk induced multiscale model: Coupled within-host and between-host dynamics and behavioral dynamics. Journal of Theoretical Biology, 599, Article 111998.
13. Wang, D., Feng, Y., Hao, J. J., et al. (2024). National and Regional Molecular Epidemiology of HIV-1-China, 2004-2023. China CDC Weekly, 6(48).
14. Chen, S. W., Ruan, Y. H., Liu, L., et al. (2024). Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China. Frontiers in Pharmacology, 15, Article 1367830.
15. Ye, Jingrong, Dong, Yuan, Lan, Yun, et al. (2024). Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023. Journal of Infectious Diseases, 230(6), 1410-1421.
16. Ye, Jingrong, Lan, Yun, Wang, Juan, et al. (2024). Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China. Journal of Infectious Diseases, 230(5), 1202-1214.
17. Chen, R., Fu, Y. Y., Li, D., et al. (2024). Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV-1 neutralizing antibodies. Journal of Medical Virology, 96(6), Article e29749.
18. Li, F. Y., Feng, Y., Liu, X., et al. (2024). HBV and HCV Co-Infection in Chinese Newly Diagnosed HIV+ Subjects in 2015 and 2023: A Cross

profiles Details
https://www.researchgate.net/scientific-contributions/Yuhua-Ruan-38393673

WOS ResearcherID: GDV-2350-2022